InvestorsHub Logo
Followers 13
Posts 1546
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Tuesday, 12/26/2023 8:11:26 PM

Tuesday, December 26, 2023 8:11:26 PM

Post# of 34625
Bristol Myers Squibb on Tuesday announced a deal to acquire RayzeBio for $4.1 billion.
RayzeBio has just TWO FDA trials going, a Phase 3 and a Phase 1 ... $4.1 billion.
NO, MRKR with a market cap of $35 million isn't undervaluded at all ???
Just Ridiculous.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News